Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 50 Key Players companies in Orally disintegrating tablet
by Highest Patent Value in the Japan in 2021

The Orally disintegrating tablet top 50 is Discovery PatSnap’ annual ranking of the top 50 Highest Patent Value Orally disintegrating tablet Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. Common among all age groups, dysphagia is observed in about 35% of the general population, as well as up to 60% of the elderly institutionalized population and 18-22% of all patients in long-term care facilities ODTs may have a faster onset of effect than tablets or capsules, and have the convenience of a tablet that can be taken without water. During the last decade, ODTs have become available in a variety of therapeutic markets, both OTC and by prescription.
#
Company Name
Region
Tech Topics
Total
1
Oncology,Medicine,Health care,
...[+2]
Avg patent value: 5.07 M
2
Fiber,Textile,Textile (markup language),
...[+2]
Avg patent value: 4.62 M
3
Clinical trial,Cardiovascular agent,Drug,
...[+2]
Avg patent value: 2.74 M
4
Avg patent value: 2.42 M
5
Avg patent value: 2.42 M
6
Medicine,Health care,Toxoid,
...[+2]
Avg patent value: 2.36 M
7
Avg patent value: 2.36 M
8
Medicine,Health care,Clinical trial,
...[+2]
Avg patent value: 1.58 M
9
Avg patent value: 1.58 M
10
Medicine,Health care,Clinical trial,
...[+2]
Avg patent value: 1.50 M
11
Avg patent value: 1.50 M
12
Avg patent value: 1.49 M
13
Avg patent value: 1.49 M
14
Avg patent value: 1.23 M
15
Avg patent value: 1.15 M
16
Avg patent value: 1.06 M
17
Avg patent value: 896,680
18
Avg patent value: 794,833
19
Drug,Health care,Clinical trial,
...[+2]
Avg patent value: 645,000
20
Avg patent value: 645,000
21
Avg patent value: 566,714
22
Avg patent value: 547,711
23
Avg patent value: 516,006
24
Health care,Drug,Medicine,
...[+2]
Avg patent value: 480,370
25
Avg patent value: 276,000
26
Avg patent value: 252,500
27
Avg patent value: 219,283
28
Biosimilar,Medicine,Health care,
...[+2]
Avg patent value: 218,333
29
Drug,Generic drug,Over-the-counter,
...[+2]
Avg patent value: 195,151
30
Toothpaste,Fast-moving consumer goods,Laundry,
...[+2]
Avg patent value: 168,250
31
Avg patent value: 115,000
32
Drug,Health care,Pharmacy,
...[+2]
Avg patent value: 97,921
33
Avg patent value: 92,000
34
Avg patent value: 92,000
35
Avg patent value: 87,000
36
Avg patent value: 84,000
37
Drug,Gastrointestinal agent,Self-medication,
...[+2]
Avg patent value: 71,000
38
Avg patent value: 58,000
39
Avg patent value: 55,000
40
Avg patent value: 55,000
41
Carbon paper,Ribbon,Carbon,
...[+1]
Avg patent value: 54,000
42
Orphan drug,Food additive,Stem cell,
...[+2]
Avg patent value: 45,710
43
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 45,000
44
Avg patent value: 43,000
45
Avg patent value: 32,500
46
Avg patent value: 27,850
47
Nutraceutical,Health care,Cosmetics,
...[+2]
Avg patent value: 12,000
48
Diagnostic agent,Health care,Drug,
...[+2]
Avg patent value: 9,957
49
Avg patent value: 3,700
50
Avg patent value: 3,700
Page generation time: May 13 2025